Novo Nordisk's semaglutide ... currently headed by Novo's own $2 billion-a-year Victoza (liraglutide) brand which stands alongside other drugs such as AstraZeneca's Bydureon (exenatide ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback